Solara Active Pharma Sciences Ltd (SOLARA) — Board Meeting | 18 September 2026

18 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Ninth AGM approved FY2025-26 financials and related party transactions

🔄 What Changed

Ratified cost auditor remuneration and approved up to Rs. 480 crores in related party transactions with Strides Pharma

🔮 What's Next

Voting results to be declared by September 22, 2026, and filed with stock exchanges

💡 Investor Takeaway

Shareholders approved key financials and related party deal, signaling confidence in company's FY2025-26 performance and governance.

Solara Active Pharma Sciences held its Ninth Annual General Meeting on September 18, 2026, via video conference, where shareholders approved the audited standalone and consolidated financial statements for FY2025-26, reappointed retiring director Arun Kumar Pillai, ratified remuneration for the cost auditor, and approved material related party transactions with Strides Pharma up to Rs. 480 crores. The meeting concluded at 11:40 A.M. IST after addressing shareholder queries, with voting results to be declared by September 22, 2026, and filed with stock exchanges.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SOLARA ✨ Ask AI About This

About Solara Active Pharma Sciences Ltd (SOLARA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹3,556.7 CrROE: -0.1%ROCE: 4.7%

View full SOLARA stock details →

📡 Get AI alerts when SOLARA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SOLARA — Free

💡 Ask AI about this filing

"How will the Strides Pharma transaction impact Solara's valuation?""What is the expected return on investment from the approved FY2025-26 financials?""When will Solara's next quarterly results be released?"

Ask AI Free →

📊 More SOLARA filings

Announcement — 26 September 2026Solara Active Pharma Sciences has sent a reminder to physical shareholders to submit valid PAN, KYC ...
Announcement — 25 September 2026Solara Active Pharma Sciences has closed its insider trading window effective October 1, 2026, ahead...
Announcement — 28 August 2026Solara Active Pharma Sciences received a rectification order from the Assistant Commissioner of Inco...
🟡 Board Meeting — 19 August 2026Solara Active Pharma announced conversion of 279,582 partly paid rights shares into fully paid share...
🟡 Board Meeting — 18 August 2026Solara Active Pharma Sciences approved the allotment of 2,250 equity shares under its Employee Stock...

See all SOLARA filings →

🔥 Also filed on 18 September 2026

MAHABANKBank of MaharashtraCorporate Action GODREJINDGodrej Industries LtdCorporate Action THEMISMEDThemis Medicare LtdCorporate Action CREDITACCCreditAccess Grameen LtdCorporate Action ARFINArfin India LtdCorporate Action GUJTHEMGujarat Themis Biosyn LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SOLARA files new disclosures

Track SOLARA filings, board meetings, and corporate actions. Free email alerts at 5 PM.